MX2018008004A - Preparacion farmaceutica compactada. - Google Patents
Preparacion farmaceutica compactada.Info
- Publication number
- MX2018008004A MX2018008004A MX2018008004A MX2018008004A MX2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical preparation
- polymer
- compacted pharmaceutical
- water
- compacted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un objeto de la presente invención es proveer una preparación farmacéutica compactada que tiene un excelente efecto de enmascaramiento de reducir un sabor desagradable provocado por un fármaco ácido y es capaz de mantener establemente una buena sensación de ingestión sin reducir el efecto de enmascaramiento en el sabor desagradable con el tiempo; una preparación farmacéutica compactada de la presente invención que logra el objeto anterior se caracteriza por que contiene partículas revestidas obtenidas al aplicar una película de un polímero soluble en los intestinos a partículas de núcleo que contienen un fármaco ácido, un polímero soluble en jugo gástrico, un polímero insoluble en agua, y un polímero soluble en agua.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015255826 | 2015-12-28 | ||
PCT/JP2016/088659 WO2017115745A1 (ja) | 2015-12-28 | 2016-12-26 | 圧縮成型製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018008004A true MX2018008004A (es) | 2019-03-28 |
Family
ID=59225052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018008004A MX2018008004A (es) | 2015-12-28 | 2016-12-26 | Preparacion farmaceutica compactada. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3398587B1 (es) |
JP (1) | JP6855387B2 (es) |
AU (1) | AU2016381918B2 (es) |
HU (1) | HUE063849T2 (es) |
MX (1) | MX2018008004A (es) |
PL (1) | PL3398587T3 (es) |
RU (1) | RU2744270C2 (es) |
WO (1) | WO2017115745A1 (es) |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
JP2516408B2 (ja) * | 1988-08-18 | 1996-07-24 | エスエス製薬株式会社 | 被覆顆粒を含む錠剤 |
ES2062527T3 (es) * | 1989-05-11 | 1994-12-16 | Chugai Pharmaceutical Co Ltd | Preparacion oral que puede ser liberada en una region apropiada del intestino. |
US5540945A (en) * | 1989-05-11 | 1996-07-30 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines |
JP2879905B2 (ja) * | 1989-08-28 | 1999-04-05 | 武田薬品工業株式会社 | イブプロフェン含有経口投与用組成物 |
IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
SE9402422D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
JP2001106639A (ja) | 1999-10-04 | 2001-04-17 | Taisho Pharmaceut Co Ltd | 経口用組成物 |
US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
JP2005187416A (ja) | 2003-12-26 | 2005-07-14 | Lion Corp | マイクロカプセル及びその製造方法 |
JP4853818B2 (ja) * | 2005-08-24 | 2012-01-11 | 大正製薬株式会社 | イブプロフェン及び塩酸アンブロキソール含有固形製剤 |
PE20080422A1 (es) * | 2006-08-10 | 2008-04-28 | Cipla Ltd | Composicion solida antirretroviral de administracion oral |
WO2008052033A2 (en) * | 2006-10-25 | 2008-05-02 | Mcneil-Ppc, Inc. | Ibuprofen composition |
JP2008231029A (ja) * | 2007-03-20 | 2008-10-02 | Ohara Yakuhin Kogyo Kk | 苦味遮蔽製剤 |
JP2009191034A (ja) * | 2008-02-15 | 2009-08-27 | Ss Pharmaceut Co Ltd | 時限放出製剤 |
JP5777273B2 (ja) | 2008-07-10 | 2015-09-09 | 大正製薬株式会社 | 不快な呈味を有する薬物を含有する製剤粒子 |
JP5578171B2 (ja) | 2009-04-09 | 2014-08-27 | ライオン株式会社 | 複合体及びその製造方法、ならびに粒状剤及び錠剤 |
RU2554740C2 (ru) * | 2009-05-01 | 2015-06-27 | Апталис Фарматек, Инк. | Композиции перорально распадающихся таблеток, содержащие комбинации высоко- и низкодозовых лекарственных средств |
KR101683293B1 (ko) | 2009-06-29 | 2016-12-06 | 라이온 가부시키가이샤 | 경구용 조성물 |
JP5549443B2 (ja) | 2009-07-15 | 2014-07-16 | ライオン株式会社 | 口腔内崩壊錠及びその製造方法 |
WO2011121824A1 (ja) * | 2010-03-29 | 2011-10-06 | アステラス製薬株式会社 | 口腔内崩壊錠 |
WO2012169614A1 (ja) * | 2011-06-10 | 2012-12-13 | ニプロ株式会社 | 口腔内崩壊錠の製造方法 |
CA2913106A1 (en) * | 2013-05-21 | 2014-11-27 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablet |
CN103860464B (zh) * | 2014-03-19 | 2016-03-16 | 广州帝奇医药技术有限公司 | 一种抗过敏药物缓释混悬剂及其制备方法 |
-
2016
- 2016-12-26 HU HUE16881720A patent/HUE063849T2/hu unknown
- 2016-12-26 RU RU2018127645A patent/RU2744270C2/ru active
- 2016-12-26 MX MX2018008004A patent/MX2018008004A/es unknown
- 2016-12-26 EP EP16881720.3A patent/EP3398587B1/en active Active
- 2016-12-26 JP JP2017559178A patent/JP6855387B2/ja active Active
- 2016-12-26 AU AU2016381918A patent/AU2016381918B2/en active Active
- 2016-12-26 PL PL16881720.3T patent/PL3398587T3/pl unknown
- 2016-12-26 WO PCT/JP2016/088659 patent/WO2017115745A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP3398587B1 (en) | 2023-08-02 |
AU2016381918A1 (en) | 2018-07-05 |
EP3398587A1 (en) | 2018-11-07 |
RU2018127645A3 (es) | 2020-04-06 |
BR112018013235A2 (pt) | 2018-12-04 |
EP3398587C0 (en) | 2023-08-02 |
WO2017115745A1 (ja) | 2017-07-06 |
JPWO2017115745A1 (ja) | 2018-10-18 |
PL3398587T3 (pl) | 2024-01-22 |
RU2018127645A (ru) | 2020-01-30 |
AU2016381918B2 (en) | 2021-11-04 |
JP6855387B2 (ja) | 2021-04-07 |
RU2744270C2 (ru) | 2021-03-04 |
HUE063849T2 (hu) | 2024-02-28 |
EP3398587A4 (en) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3405175A4 (en) | Encapsulation of Lipophilic Ingredients in Dispersible Aerosol Powder Incorporated Powder | |
EP3638248A4 (en) | CONJUGATES OF PHARMACEUTICAL INGREDIENTS | |
EP3705118A4 (en) | COMPOSITION OF AN ORAL SOLID DOSAGE FORM WITH IMPROVED RESOLUTION AND METHOD FOR MANUFACTURING IT | |
EP3556371A4 (en) | PHARMACEUTICAL COMPOSITION BASED ON SULPHONYLURIDES AND ITS PREPARATION PROCESS | |
EP3590498A4 (en) | PREPARATION WITH INCLUDING COMPLEX OF VARENICLINE OR PHARMACEUTICAL SAFE SALT THEREOF FOR ORAL ADMINISTRATION | |
MX2017003561A (es) | Composiciones y metodos para revestimientos cannabinoides para su uso en la administracion de farmacos. | |
IL280937A (en) | Dosage forms of vitamin D intended for children, methods of their preparation and use | |
PL3448363T3 (pl) | Nowa kompozycja farmaceutyczna zawierająca cząstki zawierające kompleks dwuniciowego polirybonukleotydu i polialkilenoiminy | |
IL260766B (en) | Continuous production of complexes containing active pharmaceutical ingredients | |
EP3616685A4 (en) | PROCESS FOR DETERMINING THE AUTHENTICITY OF A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, AND SYSTEM FOR DETERMINING THE AUTHENTICITY OF A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
EP3485886A4 (en) | ORAL PHARMACEUTICAL COMPOSITION MADE FROM TECOVIRIMAT AND PRODUCTION METHOD THEREFOR | |
IN2014DE00037A (es) | ||
EP3972691A4 (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DRUG OVERDOSE | |
EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
EP3400214A4 (en) | COMPOSITIONS OF 7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES FOR DRY POWDER INHALATORS | |
MX2018008004A (es) | Preparacion farmaceutica compactada. | |
EP3441076A4 (en) | PHARMACEUTICAL PRODUCT FOR THE TREATMENT OF A TUMOR AND COMBINED IMMUNE DEFECT, PREPARATION AND APPLICATION THEREOF | |
EP3277663A4 (en) | Novel drug delivery conjugated moiety for oral administration of drug unsuitable for oral administration and preparation method thereof | |
EP3681604A4 (en) | SURFACE PREPARATION ORAL FOR THE PREVENTION OF DISEASES ACQUIRED THROUGH THE ORAL CAVITY AND PHARYNX | |
EP3638209A4 (en) | NANOPARTICLE COMPOSITIONS, METHOD OF MANUFACTURING AND USE FOR DRUG DELIVERY | |
PL3326619T3 (pl) | Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę | |
EP3404054A4 (en) | PHARMACEUTICAL COMPOSITION BASED ON 5-DODECANOLID, PREPARATION AND USE THEREOF | |
MX2017000384A (es) | Forma de dosificacion en capsulas de succinato de metoprolol. | |
EP3970696A4 (en) | POWDER PREPARATION FOR TRANSNASAL ADMINISTRATION AND MANUFACTURING METHOD THEREOF | |
ZA201906202B (en) | Tetrahydrate of h3 ligand, its process of preparation and pharmaceutical compositions comprising the same |